AbbVie | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
AbbVie USD 3.32B 2.71B 2024-12
Abbott USD 49.06B 9.04B 2025-03
ALKERMES USD 1.51B 46.61M 2025-03
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eisai JPY 841.42B 31.94B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merck USD 48.34B 2.02B 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Pacira USD 798.54M 20.19M 2025-03
Perrigo USD 4.36B 44.6M 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
UCB EUR 10.03B 1.08B 2024-12
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Zoetis USD 4.66B 115M 2025-03



AbbVie Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.